000
| 01825cam 2200313zi 4500 |
---|
001 | 9.557874 |
---|
003 | CaOODSP |
---|
005 | 20210624172114 |
---|
007 | cr ||||||||||| |
---|
008 | 150406s2001||||xxc|||||o f|0| 0 eng d |
---|
020 | |a0-88659-070-1 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aC89-4/85-2001E-PDF|zC89-4/85-2001E-IN |
---|
100 | 1 |aBreau, Sébastien,|d1973- |eauthor. |
---|
245 | 10|aProfile and prospects of the biopharmaceutical industry in Atlantic Canada / |cby Sébastien Breau. |
---|
260 | |aMoncton, New Brunswick : |bAtlantic Canada Opportunities Agency, |c2001. |
---|
300 | |a1 online resource (136 pages) : |bfigures, maps, references, tables. |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
490 | 1 |aMaritime series. Monographs ; |
---|
520 | 3 |a"The present monograph...explores in greater depth the integration of biotechnologies in the pharmaceutical industry and its economic impact in Atlantic Canada. This study is part of a shared project between the CIRRD and the Atlantic Canada Opportunities Agency (ACOA). It is exploratory in nature in that it investigates some of the principal developments taking place in the biopharmaceutical industry, emphasizing the industry's recent expansion in Atlantic Canada and its characteristics as well as examining various strategies to further promote its growth"--Foreword and methodology. |
---|
590 | |a01-43|b2001-10-26 |
---|
690 | 07|aPharmaceutical industry|2gcpds |
---|
690 | 07|aAtlantic provinces|2gcpds |
---|
710 | 1 |aCanada. |bAtlantic Canada Opportunities Agency, |eissuing body. |
---|
830 | #0|aMaritime series. Monographs.|w(CaOODSP)9.504418 |
---|
856 | 40|ahttp://publications.gc.ca|qPDF|s2827 KB|uhttps://publications.gc.ca/collections/Collection/C89-4-85-2001E.pdf |
---|